Instil Bio

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$12.82
Previous Close
$13
Day Range
$12.06-$12.84
52W Range
$10.80-$42.79
Market Cap
$86.6M
Shares Short
690,632

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$138,000
Diluted EPS
-$11.35

News

See more

Yahoo Finance • 3 months ago

Instil Bio Non-GAAP EPS of -$3.24

Yahoo Finance • 3 months ago

Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Yahoo Finance • 4 months ago

ImmuneOnco Announced Preliminary Safety & Efficacy Data from the Clinical Trial Studying IMM2510/AXN-2510, a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in Front-line NSCLC in China

Yahoo Finance • 5 months ago

Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors

About

CEO
Mr. Bronson Crouch
CFO
Dr. Sandeep Laumas M.D.
Address
3963 Maple Avenue, Dallas, TX, United States, 75219
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
14